Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent return to numb the pain of a high price. It’s an opportunistic bet that claims ...

Brussels wants to coordinate a defensive shield of unmanned aerial vehicles by 2027. Its approach is bureaucratic and slow. A ...

The US pharma giant wants a court to stop biotech Metsera from ditching its deal for an $8.5 bln rival bid from Novo Nordisk. The Danish giant's cash comes with few strings, making the legal approach ...

CEO Simon Trott still has time to intervene in his London-listed rival's nil-premium offer for the $21 bln Canadian miner. Stepping in with a higher bid may work, and the returns could stack up. A ...

Welcome back! Donald Trump rated his summit with Xi Jinping a “12 out of 10”. We gave it a lower score. The confab produced an uneasy truce which did not resolve any of the tensions between the ...

A year after the bloc hiked EV import tariffs, Chinese automakers have nearly doubled overall sales there. Next, brands from BYD to Xiaomi will take aim at the premium segment. Fresh tech and ...

The activist shareholder helped the UK insurer deliver cost cuts and release capital. Axa CEO Thomas Buberl has a similar ...

Novo Nordisk muscled in on Pfizer’s bid for US drugmaker Metsera with a $9 bln offer. The $226 bln Danish group is paying a ...

Persistent budget deficits have fuelled fears the US will monetise public debt of 114% of GDP. A simple hedge is to switch to ...

Microsoft, Alphabet and Meta spent another $60 bln combined in the quest to conquer machine learning. The Windows maker can ...

The Finnish group gained over 20%, or $7 bln, after the chip giant unveiled a $1 bln investment. But the partnership is not ...

Shares of the $1.5 bln tinned fish maker Princes slipped after it priced at the bottom of the range. It adds to a dismal year ...